close
July 18, 2010
Sheraton Taipei Hotel
Taipei, Taiwan
Topic: New Era
for the Drug Discovery and Development in the Field of Renal Disease
Speaker: Toshio Miyata, MD, PhD
Professor, Center for Translational and Advanced
Research,
Tohoku University Graduate School of Medicine, Japan
Topic: Current
Diabetic Nephropathy Control In Taiwan
Speaker: Yuh-Feng Lin, MD
President, Taiwan Society of
Nephrology, Taiwan
Topic: Abnormal
Oxygen Metabolism In Diabetic Nephropathy
Speaker: Masaomi Nangaku, MD, PhD
Lecturer, Division of Nephrology and Endocrinology,
University of Tokyo School of Medicine
Topic: An
Anti-Fibrotic Approach to Identify Biomarkers of Diabetic Nephropathy
Speaker: Kumar Sharma, MD, FAHA
Professor of Medicine, University of California at San
Diego, USA
Topic:A Novel
Biomarker Panel For Diabetic Nephropathy Diagnostics And Staging
Speaker: Tzu-Ling Tseng, PhD,
Deputy General Director, Biomedical Engineering
Research Laboratories, ITRI
Topic: Current
Diabetic Control And Diabetic Complications In Taiwan
Speaker: Lee-Ming Chuang, MD, Ph.D.
President, Diabetes Association of Republic of China, Taiwan
Topic: Drug Discovery
And Development From The Academia
Targeting Carbonyl Stress In Renal Disease
Speaker: Takefumi Mori , M.D., Ph.D., FAHA
Associate Professor, Vice Director of Center for
Oxygen Medicine
Tohoku University Graduate School of Medicine
Topic: Low Grade
Albuminuria in Diabetic Patients
Speaker: Shyi-Jang Shin, MD, Ph.D
Vice Dean, School of Medicine, Kaoshiung Medical
University, Taiwan
Workshop
TOPIC 1: DN And Other Complications In Type I Diabetes
Validation of DN Staging in Type I Diabetes
TOPIC 2: DN And Other Complications In Type II Diabetes
Clarification of Early Detection and Complication
Specificity
全站熱搜
留言列表
心情 (5)